Jean-Emmanuel Sarry

35PUBLICATIONS
295CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsPredictive and prognostic markersMetabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

|Oct 06, 2026
A platform of serially transplantable AML PDX models covering subgroups for which no cell lines exist.

|Jul 23, 2026
LY3410738, a Covalent Inhibitor of Mutant IDH1/2, Is Effective in Acute Myeloid Leukemia Preclinical Models.

|Feb 24, 2026
A metabolism-specific drug-repurposing screen reveals itraconazole as a potent OXPHOS inhibitor in acute myeloid leukemia.

Ekaterini Himonas, Lucie de Beauchamp, Désirée Zerbst

|Feb 05, 2026
Succinate receptor 1 restricts hematopoiesis and prevents acute myeloid leukemia progression.

Vincent Cuminetti, Emeline Boet, Marcel Heugel

|Dec 09, 2025
Adaptation of redox metabolism in drug-tolerant persister cells is a vulnerability to prevent relapse in pancreatic cancer.

Nadine Abdel Hadi, Gabriela Reyes-Castellanos, Tristan Gicquel

|Oct 31, 2025
Metformin induces ferroptosis associated with lipidomic remodeling in AML.

Dominique Sternadt, Diego A Pereira-Martins, Prodromos Chatzikyriakou

Pageof 6

Frequent Collaborators

11 joint publications

Christian Récher

8 joint publications

Véronique Mansat-De Mas

6 joint publications

François Vergez

6 joint publications

Jérome Tamburini